Lista de obras -

Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary

article

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells

scientific article published on 01 December 2019

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

scientific article published on 05 September 2019

Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells

artículo científico publicado en 2014

Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.

scientific article published on 04 February 2014

Antitumor activity of a combination of dual PI3K/mTOR inhibitor SAR245409 and selective MEK1/2 inhibitor pimasertib in endometrial carcinomas.

artículo científico publicado en 2015

Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.

artículo científico publicado en 2016

Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer

artículo científico publicado en 2018

Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies

artículo científico publicado en 2016

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas

artículo científico publicado en 2015

Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair.

artículo científico publicado en 2014

Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer.

artículo científico publicado en 2013

Desensitization strategy for hypersensitivity reactions to carboplatin in five patients with gynecological cancer

scientific article published on 23 August 2020

Effect of MDM2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys

artículo científico publicado en 2020

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer

artículo científico publicado en 2020

Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.

artículo científico publicado en 2011

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas

artículo científico publicado en 2012

High-risk human papillomavirus correlates with recurrence after laser ablation for treatment of patients with cervical intraepithelial neoplasia 3: a long-term follow-up retrospective study

artículo científico publicado en 2013

Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas

artículo científico publicado en 2019

Increased production of inflammatory cytokines and activation of microglia in the fetal brain of preeclamptic mice induced by angiotensin II

artículo científico publicado en 2022

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas

artículo científico publicado en 2015

Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma

scientific article published on 24 September 2019

Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer

Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer.

artículo científico publicado en 2007

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

artículo científico publicado en 2016

Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma

artículo científico publicado en 2016

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer

artículo científico publicado en 2017

PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.

artículo científico publicado en 2015

Polycystic Ovarian Morphology may be a Positive Prognostic Factor in Patients with Endometrial Cancer who Achieved Complete Remission after Fertility-Sparing Therapy with Progestin

artículo científico publicado en 2017

Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study

artículo científico publicado en 2014

Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy

artículo científico publicado en 2015

Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients

artículo científico publicado en 2015

Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance

artículo científico publicado en 2017

Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression

artículo científico publicado en 2012

Repression of estrogen receptor beta function by putative tumor suppressor DBC1

artículo científico publicado en 2010

Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary.

artículo científico publicado en 2012

SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells

artículo científico publicado en 2015

Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines

artículo científico publicado en 2012

Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.

artículo científico publicado en 2016

Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging

scientific article published on 18 April 2016

The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.

artículo científico publicado en 2015

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells

scientific article published on 24 August 2020

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation

artículo científico publicado en 2019

The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma

scientific article published on 11 January 2022

The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination

artículo científico publicado en 2013

Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report

scientific article published on 27 May 2020

Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites

artículo científico publicado en 2018

[Ⅰ.Treatment for Primary Ovarian Cancer]

scientific article published on 01 February 2020

hScrib, a human homologue of Drosophila neoplastic tumor suppressor, is a novel death substrate targeted by caspase during the process of apoptosis

artículo científico publicado en 2008

Lista de obras de

Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells

Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.

Antitumor activity of a combination of dual PI3K/mTOR inhibitor SAR245409 and selective MEK1/2 inhibitor pimasertib in endometrial carcinomas.

Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.

Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer

Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas

Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair.

Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer.

Desensitization strategy for hypersensitivity reactions to carboplatin in five patients with gynecological cancer

Effect of MDM2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer

Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas

High-risk human papillomavirus correlates with recurrence after laser ablation for treatment of patients with cervical intraepithelial neoplasia 3: a long-term follow-up retrospective study

Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas

Increased production of inflammatory cytokines and activation of microglia in the fetal brain of preeclamptic mice induced by angiotensin II

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas

Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma

Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer

Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer.

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer

PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.

Polycystic Ovarian Morphology may be a Positive Prognostic Factor in Patients with Endometrial Cancer who Achieved Complete Remission after Fertility-Sparing Therapy with Progestin

Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study

Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy

Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients

Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance

Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression

Repression of estrogen receptor beta function by putative tumor suppressor DBC1

Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary.

SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells

Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines

Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.

Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging

The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation

The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma

The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination

Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report

Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites

[Ⅰ.Treatment for Primary Ovarian Cancer]

hScrib, a human homologue of Drosophila neoplastic tumor suppressor, is a novel death substrate targeted by caspase during the process of apoptosis